Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Stautz, Dorte ^a   Wewer, Ulla M ^a   Kveiborg, Marie ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12 PROTEIN; ENZYME PRECURSOR; EPIDERMAL GROWTH FACTOR; MUTANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; BREAST CANCER; BREAST CARCINOGENESIS; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME SUBSTRATE COMPLEX; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTERNALIZATION; MAMMAL CELL; MUTATIONAL ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TRANSPORT; SOMATIC MUTATION; WILD TYPE;

ADAM PROTEINS; BREAST NEOPLASMS; CELL MEMBRANE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; PROTEOLYSIS;

MAMMALIA;

EID: 84861469811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037628     Document Type: Article

References (30)

1. Edwards DR, Handsley MM, Pennington CJ, (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258-289.
2. Blobel CP, Carpenter G, Freeman M, (2009) The role of protease activity in ErbB biology. Exp Cell Res 315: 671-682.
3. Murphy G, (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 8: 929-941.
4. Murphy G, (2010) Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators. Int J Exp Pathol 91: 303-313.
5. Iba K, Albrechtsen R, Gilpin BJ, Loechel F, Wewer UM, (1999) Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 154: 1489-1501.
6. Kveiborg M, Frohlich C, Albrechtsen R, Tischler V, Dietrich N, et al. (2005) A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res 65: 4754-4761.
7. Le PH, Bonnier D, Wewer UM, Coutand A, Musso O, et al. (2003) ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37: 1056-1066.
8. Tian BL, Wen JM, Zhang M, Xie D, Xu RB, et al. (2002) The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone. Mol Pathol 55: 394-397.
9. Ohtsuka T, Shiomi T, Shimoda M, Kodama T, Amour A, et al. (2006) ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int J Cancer 118: 263-273.
10. Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Orntoft TF, et al. (2006) Molecular profiling of ADAM12 in human bladder cancer. Clin Cancer Res 12: 7359-7368.
11. Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, et al. (2008) Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev 17: 1034-1042.
12. Peduto L, Reuter VE, Sehara-Fujisawa A, Shaffer DR, Scher HI, et al. (2006) ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 25: 5462-5466.
13. Frohlich C, Nehammer C, Albrechtsen R, Kronqvist P, Kveiborg M, et al. (2011) ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression. Mol Cancer Res 9: 1449-1461.
14. Peduto L, (2009) ADAM9 as a potential target molecule in cancer. Curr Pharm Des 15: 2282-2287.
15. Jacobsen J, Wewer UM, (2009) Targeting ADAM12 in human disease: head, body or tail? Curr Pharm Des 15: 2300-2310.
16. Arribas J, Esselens C, (2009) ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Des 15: 2319-2335.
17. Wei X, Moncada-Pazos A, Cal S, Soria-Valles C, Gartner J, et al. (2011) Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma. Hum Mutat 32: E2148-E2175.
18. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
19. Dyczynska E, Syta E, Sun D, Zolkiewska A, (2008) Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. Int J Cancer 122: 2634-2640.
20. Bonifacino JS, Traub LM, (2003) Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447.
21. Pandey KN, (2009) Functional roles of short sequence motifs in the endocytosis of membrane receptors. Front Biosci 14: 5339-5360.
22. Morrison P, Chung KC, Rosner MR, (1996) Mutation of Di-leucine residues in the juxtamembrane region alters EGF receptor expression. Biochemistry 35: 14618-14624.
23. Wang Q, Zhu F, Wang Z, (2007) Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis. Exp Cell Res 313: 3349-3363.
24. Doedens JR, Black RA, (2000) Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14598-14607.
25. Atfi A, Dumont E, Colland F, Bonnier D, L'Helgoualc'h A, et al. (2007) The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor. J Cell Biol 178: 201-208.
26. Ludwig T, Theissen SM, Morton MJ, Caplan MJ, (2008) The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase. J Biol Chem 283: 35410-35418.
27. Sundberg C, Thodeti CK, Kveiborg M, Larsson C, Parker P, et al. (2004) Regulation of ADAM12 cell-surface expression by protein kinase C epsilon. J Biol Chem 279: 51601-51611.
28. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152: 181-195.
29. Kawaguchi N, Sundberg C, Kveiborg M, Moghadaszadeh B, Asmar M, et al. (2003) ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J Cell Sci 116: 3893-3904.
30. Stautz D, Sanjay A, Hansen MT, Albrechtsen R, Wewer UM, et al. (2010) ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity. Exp Cell Res 316: 55-67.